Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Pipeline celebrates Innovator of the Year, diversity of fellows’ firms (Photos)
Throughout Thursday night’s The Innovators gala, alumni of the Pipeline fellowship teased that their individual classes were the best in the entrepreneur network’s 11-year history. Newcomer to the stage Evan Luxon, however, made a case for the tight-knit 2017 fellows based on the group’s perseverance. “We’re a small, but mighty class,” said Luxon, winner of…
Surging investment network Mid-America Angels announces new director
Nebraska angel investment leader Laura McCoolidge Classen is the new managing director of Kansas City-based Mid-America Angels. Classen, who most recently served for five years as the director of Nebraska Angels, succeeds Rick Vaughn, MAA’s founding managing director. Vaughn will continue working with MAA on a part-time basis. “I enjoyed working with many colleagues in…
‘Better together’: Kansas City gaming startups level up with new entertainment venues
The eSports industry is blowing up, Brandon Williams said. And Kansas City gaming enthusiasts need places to join the party. “It’s a stereotype, but overall, gamers mostly are introverts,” said Williams, co-owner of E-Sports Bar KC in Shawnee. “It’s good to get out of the house and into a setting where there are other people…
Ex-KC Chiefs player opens coworking spa space to boost creativity, holistic wellness (Photos)
With long hours and potent job stresses, entrepreneurs often are more mindful of their business’s health than their own, said Joe Mays. The former Kansas City Chiefs linebacker teamed with his wife, Toyia, to open a coworking spa space within their holistic wellness venture, The Laya Center. Targeting individual and small-team innovators, the duo hopes…